Covance Antibody Services Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Covance Antibody Services General Information

Description

Developer of antibodies and research reagents used in neuroscience, immunopathology, cell biology, epitope tags and immunohistochemistry processes. The company also develops monoclonal antibodies and diagnostic assays for cancer, infectious disease and neurodegenerative diseases.

Contact Information

Formerly Known As
Signet Laboratories
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 180 Rustcraft Road
  • Suite 140
  • Dedham, MA 02026
  • United States
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Acquirer
BioLegend
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 180 Rustcraft Road
  • Suite 140
  • Dedham, MA 02026
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covance Antibody Services Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covance Antibody Services‘s full profile, request access.

Request a free trial

Covance Antibody Services Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covance Antibody Services‘s full profile, request access.

Request a free trial

Covance Antibody Services FAQs

  • When was Covance Antibody Services founded?

    Covance Antibody Services was founded in 1989.

  • Where is Covance Antibody Services headquartered?

    Covance Antibody Services is headquartered in Dedham, MA.

  • What industry is Covance Antibody Services in?

    Covance Antibody Services’s primary industry is Biotechnology.

  • Is Covance Antibody Services a private or public company?

    Covance Antibody Services is a Private company.

  • What is Covance Antibody Services’s current revenue?

    The current revenue for Covance Antibody Services is .

  • Who are Covance Antibody Services’s investors?

    Covance has invested in Covance Antibody Services.

  • When was Covance Antibody Services acquired?

    Covance Antibody Services was acquired on 02-Sep-2014.

  • Who acquired Covance Antibody Services?

    Covance Antibody Services was acquired by BioLegend.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process